203 related articles for article (PubMed ID: 9695649)
1. [Antihypertensive drug therapy in relation to lipid disorders].
Kawecka-Jaszcz K; Stochmal A
Przegl Lek; 1998; 55(2):85-8. PubMed ID: 9695649
[TBL] [Abstract][Full Text] [Related]
2. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
3. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
4. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
[TBL] [Abstract][Full Text] [Related]
5. Hypertension and lipids.
Sznajderman M
Blood Press Suppl; 1996; 1():14-7. PubMed ID: 9162431
[TBL] [Abstract][Full Text] [Related]
6. Metabolic disturbances and antihypertensive therapy.
Mancini M; Ferrara AL; Strazzullo P; Marotta T
J Hypertens Suppl; 1991 Dec; 9(3):S47-50. PubMed ID: 1798000
[TBL] [Abstract][Full Text] [Related]
7. Hypertension: a new perspective in therapy and metabolic effect. Part I.
Medina Ruiz A
Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome: treatment of hypertensive patients.
Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
[TBL] [Abstract][Full Text] [Related]
11. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive treatment and its implications on lipoprotein metabolism of patients in care by a hypertension and diabetes program in Brazil.
Martins RD; Alves Rde S; Silva GG; Martins N; Vasconcelos S; Assreuy A; Martins A; Goretti Queiroz M
Acta Med Port; 2008; 21(6):567-74. PubMed ID: 19331790
[TBL] [Abstract][Full Text] [Related]
13. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
Gulliford MC; Charlton J; Latinovic R
J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
[TBL] [Abstract][Full Text] [Related]
14. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
Sharma AM; Wagner T; Marsalek P
J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
16. [Arterial hypertension management in patients with type 2 diabetes].
Charpentier G; Genès N; Vaur L; Clerson P; Amar J; Guéret P; Cambou JP
Arch Mal Coeur Vaiss; 2002; 95(7-8):661-5. PubMed ID: 12365076
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive therapy of the patients with hyperlipidemia].
Umeda T; Sato T; Hamasaki S; Fujimoto Y
Nihon Rinsho; 1992 May; 50 Suppl():211-7. PubMed ID: 1512959
[No Abstract] [Full Text] [Related]
18. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
19. [Influence of cardiovascular risk factors on prescribing of antihypertensives].
Vaur L; Amar J; Perret M; Bailleau C; Etienne S; Chamontin B
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):846-50. PubMed ID: 11575216
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
